凝血酶引起血管内皮细胞渗透性改变的机制
Mechanism of Thrombin-Induced Changes in Vascular Endothelial Cell Permeability
DOI: 10.12677/HJBM.2021.112013, PDF,   
作者: 叶浩文, 李 丽*：暨南大学附属广州市红十字会医院，广东 广州
关键词: 凝血酶；血管内皮细胞；渗透性；Thrombin； Vascular Endothelial Cell； Permeability
摘要: 完整的内皮屏障功能与机体正常的生理活动密不可分，血管内皮屏障功能受损，会出现血管渗漏、水肿等一系列病理变化，而凝血酶正是目前经典的内皮屏障功能破坏剂。从18世纪至今，人们追寻于研究凝血酶诱导内皮渗透性升高的相关机制，希望能从中找到对抗凝血酶破坏屏障功能的方法。本文将针对研究中凝血酶诱导血管内皮细胞渗透性增加的机制，包括凝血酶及其受体的相关特性，以及Ca2+、PKC、Rho GTPases家族、酪氨酸激酶/磷酸酶途径等在凝血酶诱导EC渗透性增加中的作用，结合近年来有关S1P及自噬相关通路的作用作一综述。
Abstract: Intact endothelial barrier function is closely related to body physiological activities. Vascular leak-age, edema and a series of pathological changes will arise if vascular endothelial barrier function is damaged. Thrombin is the most common breaker of endothelial barrier function. Since the 18th century, researchers have investigated the mechanism of thrombin-induced increase in endothelial permeability, seeking a way to ameliorate thrombin-induced barrier disruption. This article is a summary focus on recent studies on the mechanism of thrombin inducing endothelial cell permea-bility, including the characteristics of thrombin and its receptor, and the role of Ca2+, PKC, Rho GTPases families, tyrosine kinase/phosphatase pathway, combined with the function of S1P and autophagy-related pathways.
文章引用：叶浩文, 李丽. 凝血酶引起血管内皮细胞渗透性改变的机制[J]. 生物医学, 2021, 11(2): 96-105. https://doi.org/10.12677/HJBM.2021.112013

参考文献

[1] Krüger-Genge, A., Blocki, A., Franke, R.P., et al. (2019) Vascular Endothelial Cell Biology: An Update. International Journal of Molecular Sciences, 20, 4411. [Google Scholar] [CrossRef] [PubMed]
[2] Rodrigues, S.F. and Granger, D.N. (2015) Blood Cells and Endothelial Barrier Function. Tissue Barriers, 3, e978720. [Google Scholar] [CrossRef] [PubMed]
[3] Vestweber, D., Broermann, A. and Schulte, D. (2010) Control of Endothelial Barrier Function by Regulating Vascular Endothelial-Cadherin. Current Opinion in Hematology, 17, 230-236. [Google Scholar] [CrossRef] 
[4] Wei, X.N., Han, B.C., Zhang, J.X., et al. (2011) An Integrated Mathematical Model of Thrombin-, Histamine- and VEGF-Mediated Signalling in Endothelial Permeability. BMC Systems Biology, 5, 112. [Google Scholar] [CrossRef] [PubMed]
[5] Wojciak-Stothard, B. and Ridley, A.J. (2002) Rho GTPases and the Regulation of Endothelial Permeability. Vascular Pharmacology, 39, 187-199. [Google Scholar] [CrossRef] 
[6] Tesauro, M., Mauriello, A., Rovella, V., et al. (2017) Arterial Ageing: From Endothelial Dysfunction to Vascular Calcification. Journal of Internal Medicine, 281, 471-482. [Google Scholar] [CrossRef] [PubMed]
[7] Mundi, S., Massaro, M., Scoditti, E., et al. (2018) Endothelial Permeability, LDL Deposition, and Cardiovascular Risk Factors—A Review. Cardiovascular Research, 114, 35-52. [Google Scholar] [CrossRef] [PubMed]
[8] Malik, A.B., Lo, S.K. and Bizios, R. (1986) Thrombin-Induced Alterations in Endothelial Permeability. Annals of the New York Academy of Sciences, 485, 293-309. [Google Scholar] [CrossRef] [PubMed]
[9] Coughlin, S.R. (2000) Thrombin Signalling and Protease-Activated Receptors. Nature, 407, 258-264. [Google Scholar] [CrossRef] [PubMed]
[10] Di Cera, E. (2008) Thrombin. Molecular Aspects of Medicine, 29, 203-254. [Google Scholar] [CrossRef] [PubMed]
[11] Cleator, J.H. and Vaughan, D.E. (2008) Clinical Implications of the Contrasting Effects of in Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature. Journal of the American College of Cardiology, 51, 1757-1759. [Google Scholar] [CrossRef] [PubMed]
[12] Martorell, L., Martínez-González, J., Rodríguez, C., et al. (2008) Thrombin and Protease-Activated Receptors (PARs) in Atherothrombosis. Thrombosis and Haemostasis, 99, 305-315. [Google Scholar] [CrossRef] 
[13] Gandhi, P.S., Chen, Z., Appelbaum, E., et al. (2011) Structural Basis of Thrombin-Protease-Activated Receptor Interactions. IUBMB Life, 63, 375-382. [Google Scholar] [CrossRef] [PubMed]
[14] Korhonen, H., Fisslthaler, B., Moers, A., et al. (2009) Anaphylactic Shock Depends on Endothelial Gq/G11. Journal of Experimental Medicine, 206, 411-420. [Google Scholar] [CrossRef] [PubMed]
[15] Troyanovsky, B., Alvarez, D.F., King, J.A., et al. (2008) Thrombin Enhances the Barrier Function of Rat Microvascular Endothelium in a PAR-1-Dependent Manner. American Journal of Physiology-Lung Cellular and Molecular Physiology, 294, L266-L275. [Google Scholar] [CrossRef] [PubMed]
[16] Stavenuiter, F. and Mosnier, L.O. (2014) Noncanonical PAR3 Activation by Factor Xa Identifies a Novel Pathway for Tie2 Activation and Stabilization of Vascular Integrity. Blood, 124, 3480-3489. [Google Scholar] [CrossRef] [PubMed]
[17] McLaughlin, J.N., Patterson, M.M. and Malik, A.B. (2007) Protease-Activated Receptor-3 (PAR3) Regulates PAR1 Signaling by Receptor Dimerization. Proceedings of the National Academy of Sciences of the United States of America, 104, 5662-5667. [Google Scholar] [CrossRef] [PubMed]
[18] Grimsey, N.J. and Trejo, J. (2016) Integration of Endothelial Protease-Activated Receptor-1 Inflammatory Signaling by Ubiquitin. Current Opinion in Hematology, 23, 274-279. [Google Scholar] [CrossRef] 
[19] DeMichele, M.A., Moon, D.G., Fenton, J.W., et al. (1990) Thrombin’s Enzymatic Activity Increases Permeability of Endothelial Cell Monolayers. Journal of Applied Physiology (1985), 69, 1599-1606. [Google Scholar] [CrossRef] [PubMed]
[20] Aschner, J.L., Lennon, J.M., Fenton, J.W., et al. (1990) Enzymatic Activity Is Necessary for Thrombin-Mediated Increase in Endothelial Permeability. American Journal of Physiology, 259, L270-L275. [Google Scholar] [CrossRef] 
[21] Malik, A.B. and Fenton, J.W. (1992) Thrombin-Mediated Increase in Vascular Endothelial Permeability. Seminars in Thrombosis and Hemostasis, 18, 193-199. [Google Scholar] [CrossRef] [PubMed]
[22] Lum, H., Del Vecchio, P.J., Schneider, A.S., et al. (1989) Calcium Dependence of the Thrombin-Induced Increase in Endothelial Albumin Permeability. Journal of Applied Physiology (1985), 66, 1471-1476. [Google Scholar] [CrossRef] [PubMed]
[23] Garcia, J.G., Verin, A.D. and Schaphorst, K.L. (1996) Regulation of Thrombin-Mediated Endothelial Cell Contraction and Permeability. Seminars in Thrombosis and Hemostasis, 22, 309-315. [Google Scholar] [CrossRef] [PubMed]
[24] Dalal, P.J., Muller, W.A. and Sullivan, D.P. (2020) Endothelial Cell Calcium Signaling during Barrier Function and Inflammation. The American Journal of Pathology, 190, 535-542. [Google Scholar] [CrossRef] [PubMed]
[25] Clapham, D.E. (2007) Calcium Signaling. Cell, 131, 1047-1058. [Google Scholar] [CrossRef] [PubMed]
[26] Tiruppathi, C., Minshall, R.D., Paria, B.C., et al. (2002) Role of Ca2+ Signaling in the Regulation of Endothelial Permeability. Vascular Pharmacology, 39, 173-185. [Google Scholar] [CrossRef] 
[27] Stolwijk, J.A., Zhang, X., Gueguinou, M., et al. (2016) Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function. Journal of Biological Chemistry, 291, 22894-22912. [Google Scholar] [CrossRef] 
[28] Weber, E.W., Han, F., Tauseef, M., et al. (2015) TRPC6 Is the Endothelial Calcium Channel That Regulates Leukocyte Transendothelial Migration during the Inflammatory Response. Journal of Experimental Medicine, 212, 1883-1899. [Google Scholar] [CrossRef] [PubMed]
[29] Borbiev, T., Verin, A.D., Shi, S., et al. (2001) Regulation of Endothelial Cell Barrier Function by Calcium/Calmodulin- Dependent Protein Kinase II. American Journal of Physiology-Lung Cellular and Molecular Physiology, 280, L983-L990. [Google Scholar] [CrossRef] 
[30] Luo, M., Flood, E.C., Almeida, D., Yan, L., Berlin, D.A., Heerdt, P.M. and Hajjar, K.A. (2017) Annexin A2 Supports Pulmonary Microvascular Integrity by Linking Vascular Endothelial Cadherin and Protein Tyrosine Phosphatases. Journal of Experimental Medicine, 214, 2535-2545. [Google Scholar] [CrossRef] [PubMed]
[31] Gschwendt, M. (1999) Protein Kinase C Delta. European Journal of Biochemistry, 259, 555-564. [Google Scholar] [CrossRef] [PubMed]
[32] Stasek, J.E., Patterson, C.E. and Garcia, J.G. (1992) Protein Kinase C Phosphorylates Caldesmon 77 and Vimentin and Enhances Albumin Permeability across Cultured Bovine Pulmonary Artery Endothelial Cell Monolayers. Journal of Cellular Physiology, 153, 62-75. [Google Scholar] [CrossRef] [PubMed]
[33] Xia, X., Mariner, D.J. and Reynolds, A.B. (2003) Adhesion-Associated and PKC-Modulated Changes in Serine/Threonine Phosphorylation of p120-Catenin. Biochemistry, 42, 9195-9204. [Google Scholar] [CrossRef] [PubMed]
[34] Rabiet, M.J., Plantier, J.L., Rival, Y., et al. (1996) Thrombin-Induced Increase in Endothelial Permeability Is Associated with Changes in Cell-to-Cell Junction Organization. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 488-496. [Google Scholar] [CrossRef] 
[35] Mehta, D., Rahman, A. and Malik, A.B. (2001) Protein Kinase C-Alpha Signals Rho-Guanine Nucleotide Dissociation Inhibitor Phosphorylation and Rho Activation and Regulates the Endothelial Cell Barrier Function. Journal of Biological Chemistry, 276, 22614-22620. [Google Scholar] [CrossRef] 
[36] Minshall, R.D., Vandenbroucke, E.E., Holinstat, M., et al. (2010) Role of Protein Kinase Czeta in Thrombin-Induced RhoA Activation and Inter-Endothelial Gap Formation of Human Dermal Microvessel Endothelial Cell Monolayers. Microvascular Research, 80, 240-249. [Google Scholar] [CrossRef] [PubMed]
[37] Ridley, A.J. (2013) RhoA, RhoB and RhoC Have Different Roles in Cancer Cell Migration. Journal of Microscopy, 251, 242-249. [Google Scholar] [CrossRef] [PubMed]
[38] Essler, M., Amano, M., Kruse, H.J., et al. (1998) Thrombin Inactivates Myosin Light Chain Phosphatase via Rho and Its Target Rho Kinase in Human Endothelial Cells. Journal of Biological Chemistry, 273, 21867-21874. [Google Scholar] [CrossRef] [PubMed]
[39] Pronk, M.C.A., van Bezu, J.S.M., van Nieuw Amerongen, G.P., et al. (2019) RhoA, RhoB and RhoC Differentially Regulate Endothelial Barrier Function. Small GTPases, 10, 466-484. [Google Scholar] [CrossRef] [PubMed]
[40] Russo, A., Soh, U.J., Paing, M.M., et al. (2009) Caveolae Are Required for Protease-Selective Signaling by Protease-Activated Receptor-1. Proceedings of the National Academy of Sciences of the United States of America, 106, 6393-6397. [Google Scholar] [CrossRef] [PubMed]
[41] van Nieuw Amerongen, G.P., van Delft, S., Vermeer, M.A., et al. (2000) Activation of RhoA by Thrombin in Endothelial Hyperpermeability: Role of Rho Kinase and Protein Tyrosine Kinases. Circulation Research, 87, 335-340. [Google Scholar] [CrossRef] 
[42] Wójciak-Stothard, B., Potempa, S., Eichholtz, T., et al. (2001) Rho and Rac but Not Cdc42 Regulate Endothelial Cell Permeability. Journal of Cell Science, 114, 1343-1355.
[43] Aslam, M., Tanislav, C., Troidl, C., et al. (2014) cAMP Controls the Restoration of Endothelial Barrier Function after Thrombin-Induced Hyperpermeability via Rac1 Activation. Physiological Reports, 2, e12175. [Google Scholar] [CrossRef] [PubMed]
[44] Parker, W.H., Qu, Z.C. and May, J.M. (2015) Intracellular Ascorbate Prevents Endothelial Barrier Permeabilization by Thrombin. Journal of Biological Chemistry, 290, 21486-21497. [Google Scholar] [CrossRef] 
[45] Zhang, W. and Colman, R.W. (2007) Thrombin Regulates Intracellular Cyclic AMP Concentration in Human Platelets through Phosphorylation/Activation of Phosphodiesterase 3A. Blood, 110, 1475-1482. [Google Scholar] [CrossRef] [PubMed]
[46] Sanz, M.J., Cortijo, J., Taha, M.A., et al. (2007) Roflumilast Inhibits Leukocyte-Endothelial Cell Interactions, Expression of Adhesion Molecules and Microvascular Permeability. British Journal of Pharmacology, 152, 481-492. [Google Scholar] [CrossRef] [PubMed]
[47] Werthmann, R.C., Lohse, M.J. and Bünemann, M. (2011) Temporally Resolved cAMP Monitoring in Endothelial Cells Uncovers a Thrombin-Induced [cAMP] Elevation Mediated via the Ca²+-Dependent Production of Prostacyclin. The Journal of Physiology, 589, 181-193. [Google Scholar] [CrossRef] [PubMed]
[48] Baumer, Y., Spindler, V., Werthmann, R.C., et al. (2009) Role of Rac1 and cAMP in Endothelial Barrier Stabilization and Thrombin-Induced Barrier Breakdown. Journal of Cellular Physiology, 220, 716-726. [Google Scholar] [CrossRef] [PubMed]
[49] Bernard, O. (2007) Lim Kinases, Regulators of Actin Dynamics. The International Journal of Biochemistry & Cell Biology, 39, 1071-1076. [Google Scholar] [CrossRef] [PubMed]
[50] Birukova, A.A., Alekseeva, E., Mikaelyan, A., et al. (2007) HGF Attenuates Thrombin-Induced Endothelial Permeability by Tiam1-Mediated Activation of the Rac Pathway and by Tiam1/Rac-Dependent Inhibition of the Rho Pathway. FASEB Journal, 21, 2776-2786. [Google Scholar] [CrossRef] [PubMed]
[51] Aslam, M., Härtel, F.V., Arshad, M., et al. (2010) cAMP/PKA Antagonizes Thrombin-Induced Inactivation of Endothelial Myosin Light Chain Phosphatase: Role of CPI-17. Cardiovascular Research, 87, 375-384. [Google Scholar] [CrossRef] [PubMed]
[52] Grinnell, K.L., Casserly, B. and Harrington, E.O. (2010) Role of Protein Tyrosine Phosphatase SHP2 in Barrier Function of Pulmonary Endothelium. American Journal of Physiology-Lung Cellular and Molecular Physiology, 298, L361-L370. [Google Scholar] [CrossRef] [PubMed]
[53] Ukropec, J.A., Hollinger, M.K., Salva, S.M., et al. (2000) SHP2 Association with VE-Cadherin Complexes in Human Endothelial Cells Is Regulated by Thrombin. Journal of Biological Chemistry, 275, 5983-5986. [Google Scholar] [CrossRef] [PubMed]
[54] Timmerman, I., Hoogenboezem, M., Bennett, A.M., et al. (2012) The Tyrosine Phosphatase SHP2 Regulates Recovery of Endothelial Adherens Junctions through Control of β-Catenin Phosphorylation. Molecular Biology of the Cell, 23, 4212-4225. [Google Scholar] [CrossRef] [PubMed]
[55] Chichger, H., Braza, J., Duong, H., et al. (2015) SH2 Domain-Containing Protein Tyrosine Phosphatase 2 and Focal Adhesion Kinase Protein Interactions Regulate Pulmonary Endothelium Barrier Function. American Journal of Respiratory Cell and Molecular Biology, 52, 695-707. [Google Scholar] [CrossRef] 
[56] Schaphorst, K.L., Pavalko, F.M., Patterson, C.E., et al. (1997) Thrombin-Mediated Focal Adhesion Plaque Reorganization in Endothelium: Role of Protein Phosphorylation. American Journal of Respiratory Cell and Molecular Biology, 17, 443-455. [Google Scholar] [CrossRef] [PubMed]
[57] van Nieuw Amerongen, G.P., Natarajan, K., Yin, G., et al. (2004) GIT1 Mediates Thrombin Signaling in Endothelial Cells: Role in Turnover of RhoA-Type Focal Adhesions. Circulation Research, 94, 1041-1049. [Google Scholar] [CrossRef] 
[58] Kurano, M. and Yatomi, Y. (2018) Sphingosine 1-Phosphate and Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 25, 16-26. [Google Scholar] [CrossRef] 
[59] Sanchez, T., Skoura, A., Wu, M.T., et al. (2007) Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor-2 (S1P2R) and Its Downstream Effectors ROCK and PTEN. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1312-1318. [Google Scholar] [CrossRef] 
[60] Niessen, F., Schaffner, F., Furlan-Freguia, C., et al. (2008) Dendritic Cell PAR1-S1P3 Signalling Couples Coagulation and Inflammation. Nature, 452, 654-658. [Google Scholar] [CrossRef] [PubMed]
[61] Feistritzer, C. and Riewald, M. (2005) Endothelial Barrier Protection by Activated Protein C through PAR1-Dependent Sphingosine 1-Phosphate Receptor-1 Cross-Activation. Blood, 105, 3178-3184. [Google Scholar] [CrossRef] [PubMed]
[62] Mahajan-Thakur, S., Böhm, A., Jedlitschky, G., et al. (2015) Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation. Mediators of Inflammation, 2015, Article ID: 831059. [Google Scholar] [CrossRef] [PubMed]
[63] Sun, X.J., Chen, M. and Zhao, M.H. (2019) Thrombin Contributes to Anti-Myeloperoxidase Antibody Positive IgG-Mediated Glomerular Endothelial Cells Activation through SphK1-S1P-S1PR3 Signaling. Frontiers in Immunology, 10, 237. [Google Scholar] [CrossRef] [PubMed]
[64] Tauseef, M., Kini, V., Knezevic, N., et al. (2008) Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells. Circulation Research, 103, 1164-1172. [Google Scholar] [CrossRef] 
[65] Komarova, Y.A., Mehta, D. and Malik, A.B. (2007) Dual Regulation of Endothelial Junctional Permeability. Science’s STKE, 2007, re8. [Google Scholar] [CrossRef] [PubMed]
[66] Yu, L., Chen, Y. and Tooze, S.A. (2018) Autophagy Pathway: Cellular and Molecular Mechanisms. Autophagy, 14, 207-215. [Google Scholar] [CrossRef] [PubMed]
[67] Chao, C.H., Chen, H.R., Chuang, Y.C., et al. (2018) Macrophage Migration Inhibitory Factor-Induced Autophagy Contributes to Thrombin-Triggered Endothelial Hyperpermeability in Sepsis. Shock, 50, 103-111. [Google Scholar] [CrossRef] 
[68] Wadgaonkar, R., Dudek, S.M., Zaiman, A.L., et al. (2005) Intracellular Interaction of Myosin Light Chain Kinase with Macrophage Migration Inhibition Factor (MIF) in Endothelium. Journal of Cellular Biochemistry, 95, 849-858. [Google Scholar] [CrossRef] [PubMed]
[69] Leonard, A., Millar, M.W., Slavin, S.A., et al. (2019) Critical Role of Autophagy Regulator Beclin1 in Endothelial Cell Inflammation and Barrier Disruption. Cell Signaling, 61, 120-129. [Google Scholar] [CrossRef] [PubMed]
[70] Shadab, M., Millar, M.W., Slavin, S.A., et al. (2020) Autophagy Protein ATG7 Is a Critical Regulator of Endothelial Cell Inflammation and Permeability. Scientific Reports, 10, Article No. 13708. [Google Scholar] [CrossRef] [PubMed]

为你推荐